Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)
Hong Kong · Delayed Price · Currency is HKD 22.00
-0.94 (-4.10%)
May 12, 2026, 4:08 PM HKT
Xuanzhu Biopharmaceutical Revenue
In the year 2025, Xuanzhu Biopharmaceutical had annual revenue of 51.77M CNY with 72.03% growth. Xuanzhu Biopharmaceutical had revenue of 33.88M in the half year ending December 31, 2025.
Revenue
51.77M CNY
Revenue Growth
+72.03%
P/S Ratio
206.24
Revenue / Employee
262.80K CNY
Employees
197
Market Cap
11.88B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 51.77M | 21.68M | 72.03% |
| Dec 31, 2024 | 30.09M | 30.07M | 103,672.41% |
| Dec 31, 2023 | 29.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Traditional Chinese Medicine Holdings Co. | 16.41B |
| Shandong Xinhua Pharmaceutical Company | 9.94B |
| Luye Pharma Group | 7.02B |
| SSY Group | 4.17B |
| Consun Pharmaceutical Group | 3.80B |
| China Shineway Pharmaceutical Group | 3.49B |
| Sihuan Pharmaceutical Holdings Group | 2.91B |
| CanSino Biologics | 1.27B |